EXEL
NASDAQ · Biotechnology
Exelixis Inc
$58.15
+0.93 (+1.63%)
Analyst Consensus
Hold
27
Analysts
High
Coverage
Price Target
Analyst Price Target
+99.7% upside
Low Target
$78.53
Average Target
$116.10
High Target
$123.77
Current Price
$58.15
Current
$58.15
$58.15
Target
$116.10
$116.10
$78.53
$116.10 avg
$123.77
Scenario Analysis
Bear Case
$78.53
35.0%
Low target
Base Case
$116.10
+99.7%
Avg target
Bull Case
$123.77
+112.8%
High target
Risk/Reward
3.2x
Highly favorable
Price in Context
52-Week High
$59.72
-2.6% from high
52-Week Low
$33.76
+72.2% from low
50-Day SMA
$43.59
+33.4% vs SMA
200-Day SMA
$41.49
+40.2% vs SMA
RSI (14)
62.0
Neutral
Target vs 52W High
$116.10
+94.4% vs high
Peer Consensus — Biotechnology
| Stock | Consensus | Analysts | Buy % | Target | Upside |
|---|---|---|---|---|---|
| ABBV | Strong Buy | 39 | 82% | $257.58 | -2.9% |
| AMGN | Hold | 43 | 47% | $190.87 | -53.5% |
| GILD | Strong Buy | 37 | 81% | $362.68 | +137.6% |
| VRTX | Strong Buy | 36 | 81% | $438.34 | -14.9% |
| REGN | Buy | 38 | 68% | $76.80 | -90.4% |
| MRNA | Hold | 30 | 37% | $149.45 | -18.1% |
| NTRA | Strong Buy | 30 | 87% | $142.91 | -63.4% |
| RVMD | Strong Buy | 28 | 93% | $114.11 | -40.8% |